Technical Analysis for JNJ - Johnson & Johnson

Grade Last Price % Change Price Change
D 153.32 0.14% 0.21
JNJ closed up 0.07 percent on Wednesday, November 20, 2024, on 1.43 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
21 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Flat

Date Alert Name Type % Chg
Pocket Pivot Bullish Swing Setup 0.14%
NR7 Range Contraction 0.14%
NR7-2 Range Contraction 0.14%
Fell Below 200 DMA Bearish 0.21%
NR7 Range Contraction 0.21%
Gapped Down Weakness 0.21%
Crossed Above 200 DMA Bullish -0.94%
Gapped Down Weakness -0.94%
Oversold Stochastic Weakness -0.94%
Slingshot Bearish Bearish Swing Setup -0.44%

   Recent Intraday Alerts

Alert Time
Rose Above Previous Day's High about 1 hour ago
10 DMA Resistance about 1 hour ago
Possible NR7 about 21 hours ago
2x Volume Pace 1 day ago
1.5x Volume Pace 1 day ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Johnson & Johnson Description

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The Consumer segment offers products used in the baby care, skin care, oral care, wound care, and women's health fields, as well as nutritional and over-the-counter pharmaceutical products, and wellness and prevention platforms under the JOHNSON'S, AVEENO, CLEAN & CLEAR, NEUTROGENA, RoC, LUBRIDERM, DABAO, VENDÔME, LISTERINE, REMBRANDT, REACH, BAND-AID, NEOSPORIN, CAREFREE, STAYFREE, SPLENDA, TYLENOL, SUDAFED, ZYRTEC, MOTRIN IB, and PEPCID AC brand names. This segment markets its products to the general public, as well as to retail outlets and distributors. The Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, neurology, oncology, pain management, thrombosis, and vaccines. This segment distributes its products directly to retailers, wholesalers, and health care professionals for prescription use. The Medical Devices and Diagnostics segment offers products to treat cardiovascular disease; orthopaedic and neurological products; blood glucose monitoring and insulin delivery products; general surgery, biosurgical, and energy products; professional diagnostic products; infection prevention products; and disposable contact lenses. This segment distributes its products directly, as well as through surgical supply and other distributors to wholesalers, hospitals, and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: S&P 500 Immunology Pain Infectious Diseases Pharmaceutical Products Retail Outlets Dow Jones Component Infection Gastrointestinal Pharmacology Skin Care Cardiovascular Disease Urology Glucose Pain Management Hematology Wound Diagnostic Products Energy Products Insulin Neurology Blood Glucose Monitoring Lenses Contact Lens Contact Lenses General Surgery Infection Prevention Thrombosis Antipsychotic Infection Prevention Products Insulin Delivery Johnson & Johnson Urological Products

Is JNJ a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 168.85
52 Week Low 140.9128
Average Volume 6,317,436
200-Day Moving Average 154.59
50-Day Moving Average 160.59
20-Day Moving Average 157.06
10-Day Moving Average 153.99
Average True Range 2.37
RSI (14) 35.06
ADX 23.32
+DI 14.06
-DI 25.06
Chandelier Exit (Long, 3 ATRs) 158.89
Chandelier Exit (Short, 3 ATRs) 157.87
Upper Bollinger Bands 163.93
Lower Bollinger Band 150.19
Percent B (%b) 0.21
BandWidth 8.75
MACD Line -2.35
MACD Signal Line -2.05
MACD Histogram -0.3048
Fundamentals Value
Market Cap 368.58 Billion
Num Shares 2.41 Billion
EPS 5.20
Price-to-Earnings (P/E) Ratio 29.44
Price-to-Sales 4.43
Price-to-Book 5.30
PEG Ratio 5.77
Dividend 4.70
Dividend Yield 3.07%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 155.27
Resistance 3 (R3) 155.08 154.16 154.91
Resistance 2 (R2) 154.16 153.61 154.26 154.79
Resistance 1 (R1) 153.64 153.27 153.90 153.83 154.67
Pivot Point 152.72 152.72 152.86 152.82 152.72
Support 1 (S1) 152.20 152.17 152.46 152.39 151.55
Support 2 (S2) 151.28 151.83 151.38 151.43
Support 3 (S3) 150.76 151.28 151.31
Support 4 (S4) 150.95